Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan · Delayed Price · Currency is TWD 68.10
-0.40 (-0.58%)
May 15, 2026, 1:30 PM CST
Excelsior Medical Market Cap
Excelsior Medical has a market cap or net worth of 11.75 billion as of May 15, 2026. Its market cap has decreased by -18.73% in one year.
Market Cap
11.75B
Enterprise Value
12.90B
Revenue
8.79B
Ranking
n/a
PE Ratio
14.64
Stock Price
68.10
Market Cap Chart
Since July 3, 2003, Excelsior Medical's market cap has increased from 2.50B to 11.75B, an increase of 370.30%. That is a compound annual growth rate of 7.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 11.75B | -16.05% |
| Dec 31, 2025 | 14.00B | -0.37% |
| Dec 31, 2024 | 14.05B | 2.15% |
| Dec 29, 2023 | 13.76B | 37.31% |
| Dec 30, 2022 | 10.02B | 23.23% |
| Dec 30, 2021 | 8.13B | 2.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 290.25B |
| Caliway Biopharmaceuticals | 151.59B |
| Lotus Pharmaceutical | 52.04B |
| Heron Neutron Medical | 50.72B |
| Foresee Pharmaceuticals | 12.49B |
| EirGenix | 12.27B |
| Ever Supreme Bio Technology | 12.18B |
| Visco Vision | 11.97B |